Psychedelics Pharma giant AbbVie to spend over US$1B on Gilgamesh’s lead psychedelic One of the biggest deals of all time in the industry Rowan DunneAugust 27, 2025
Sleep Sleep.ai scoops US$5.5M to advance its nighttime data analysis platform The company's SleepScore app is one of the world's top sleep intelligence tools Rowan DunneAugust 27, 2025
Alternative Energy Scientists create ‘breathing’ crystal with massive clean energy implications It's a special metal oxide comprised of strontium, iron and cobalt Rowan DunneAugust 26, 2025
Alternative Energy Hydrogen sector faces reality check as BP, Origin, and others exit ventures Developers have cancelled nearly one in four announced ventures, equal to about 6 million tonnes per annum of planned capacity Joseph MortonAugust 26, 2025
Alternative Energy Province of Alberta launches public consultation on nuclear power The public can participate through the Nuclear Energy Development survey, which remains open online until Sept. 25 Joseph MortonAugust 26, 2025
Mining Energy Fuels and Vulcan Elements forge rare earth alliance This collaboration is a byproduct of the urgency of developing a U.S.-based supply chain independent of China Joseph MortonAugust 26, 2025
Crypto/Blockchain US lawmaker proposes private action against global crypto criminals This safeguard would ensure compliance with federal directives and limit abuse Joseph MortonAugust 26, 2025
Cannabis Google Ads starts Canadian cannabis advertising pilot It is restricted to federally licensed operators, the tech giant has specified Rowan DunneAugust 26, 2025
Mining Locksley Resources announces pivotal American antimony partnerships The company is collaborating with a top Texas school and critical minerals advisory group in Washington D.C. Rowan DunneAugust 26, 2025
Medical and Pharmaceutical Penn State pioneers diabetes breath test that provides results in minutes New developments with breath analysis technology have made diagnosing several diseases easier than ever Rowan DunneAugust 25, 2025